Ken Griffin Davita Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$133.98 - $165.19 $24.8 Million - $30.6 Million	-185,200 Reduced 37.87%	303,900 $49.8 Million
Q2 2024 Aug 14, 2024	SELL	$126.11 - $147.14 $18.2 Million - $21.2 Million	-144,300 Reduced 22.78%	489,100 $67.8 Million
Q1 2024 May 15, 2024	BUY	$103.89 - $139.21 $19.4 Million - $26 Million	186,900 Added 41.86%	633,400 $87.4 Million
Q4 2023 Feb 14, 2024	BUY	$73.2 - $108.8 $1.28 Million - $1.9 Million	17,500 Added 4.08%	446,500 $46.8 Million
Q3 2023 Nov 14, 2023	BUY	$94.53 - $112.68 $2.86 Million - $3.41 Million	30,300 Added 7.6%	429,000 $40.6 Million
Q2 2023 Aug 14, 2023	BUY	$81.58 - $100.93 $20.4 Million - $25.2 Million	249,500 Added 167.23%	398,700 $40.1 Million
Q1 2023 May 15, 2023	SELL	$74.68 - $85.82 $15.4 Million - $17.7 Million	-206,000 Reduced 58.0%	149,200 $12.1 Million
Q4 2022 Feb 14, 2023	BUY	$65.42 - $99.31 $1.43 Million - $2.16 Million	21,800 Added 6.54%	355,200 $26.5 Million
Q3 2022 Nov 14, 2022	SELL	$80.24 - $95.27 $906,712 - $1.08 Million	-11,300 Reduced 3.28%	333,400 $27.6 Million

662

74.4M

1.41M

1.82M

Ticker DVA
Exchange NYSE
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 91,300,000
Market Cap $14.7B
Description
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine lab...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.